Folgen
Hertzel Gerstein
Hertzel Gerstein
Bestätigte E-Mail-Adresse bei mcmaster.ca
Titel
Zitiert von
Zitiert von
Jahr
Effects of intensive glucose lowering in type 2 diabetes
Action to Control Cardiovascular Risk in Diabetes Study Group
New England journal of medicine 358 (24), 2545-2559, 2008
91782008
Effects of intensive blood-pressure control in type 2 diabetes mellitus
ACCORD Study Group
New England Journal of Medicine 362 (17), 1575-1585, 2010
39522010
Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy
Heart Outcomes Prevention Evaluation (HOPE) Study Investigators
The lancet 355 (9200), 253-259, 2000
34152000
Effects of combination lipid therapy in type 2 diabetes mellitus
ACCORD Study Group
New England Journal of Medicine 362 (17), 1563-1574, 2010
30902010
Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals
HC Gerstein, JFE Mann, Q Yi, B Zinman, SF Dinneen, B Hoogwerf, ...
Jama 286 (4), 421-426, 2001
30332001
Users' guides to the medical literature: III. How to use an article about a diagnostic test B. What are the results and will they help me in caring for my patients?
R Jaeschke, GH Guyatt, DL Sackett, G Guyatt, E Bass, P Brill-Edwards, ...
Jama 271 (9), 703-707, 1994
29161994
Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview
SE Capes, D Hunt, K Malmberg, HC Gerstein
The Lancet 355 (9206), 773-778, 2000
28422000
The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years.
M Coutinho, HC Gerstein, Y Wang, S Yusuf
Diabetes care 22 (2), 233-240, 1999
26111999
Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview
SE Capes, D Hunt, K Malmberg, P Pathak, HC Gerstein
Stroke 32 (10), 2426-2432, 2001
23352001
Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial
DREAM (Diabetes REduction Assessment with ramipril and rosiglitazone ...
The Lancet 368 (9541), 1096-1105, 2006
21382006
Lixisenatide in patients with type 2 diabetes and acute coronary syndrome
MA Pfeffer, B Claggett, R Diaz, K Dickstein, HC Gerstein, LV Køber, ...
New England Journal of Medicine 373 (23), 2247-2257, 2015
20672015
Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association
JB Buse, HN Ginsberg, GL Bakris, NG Clark, F Costa, R Eckel, V Fonseca, ...
Circulation 115 (1), 114-126, 2007
19042007
Basal insulin and cardiovascular and other outcomes in dysglycemia
ORIGIN Trial Investigators
New England Journal of Medicine 367 (4), 319-328, 2012
17922012
Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial
JFE Mann, HC Gerstein, J Pogue, J Bosch, S Yusuf, Hope Investigators
Annals of internal medicine 134 (8), 629-636, 2001
17692001
Users' guides to the medical literature: II. How to use an article about therapy or prevention A. Are the results of the study valid?
GH Guyatt, DL Sackett, DJ Cook, G Guyatt, E Bass, P Brill-Edwards, ...
Jama 270 (21), 2598-2601, 1993
15681993
Users' Guides to the Medical Literature: III. How to Use an Article About a Diagnostic Test A. Are the Results of the Study Valid?
R Jaeschke, G Guyatt, DL Sackett, E Bass, P Brill-Edwards, G Browman, ...
Jama 271 (5), 389-391, 1994
15231994
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
HC Gerstein, HM Colhoun, GR Dagenais, R Diaz, M Lakshmanan, P Pais, ...
The Lancet 394 (10193), 121-130, 2019
14132019
Effects of medical therapies on retinopathy progression in type 2 diabetes
FLJ Chew EY, Ambrosius WT, Davis MD, Danis RP, Gangaputra S, Greven CM ...
New Engl J Med. 363 (3), 233-44, 2010
1376*2010
Users' guides to the medical literature: VI. How to use an overview
AD Oxman, DJ Cook, GH Guyatt, E Bass, P Brill-Edwards, G Browman, ...
Jama 272 (17), 1367-1371, 1994
13351994
Intensive glucose control and macrovascular outcomes in type 2 diabetes
FM Turnbull, C Abraira, RJ Anderson, RP Byington, JP Chalmers, ...
Diabetologia 52 (11), 2288-2298, 2009
13172009
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20